Malmö University Publications
Planned maintenance
A system upgrade is planned for 24/9-2024, at 12:00-14:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mesoporous silica particles as lipophilic drug vehicle investigated by fluorescence lifetime imaging
Nanologica AB, Södertälje, Sweden.ORCID iD: 0000-0002-2535-7108
CNR, ISOF, Via Gobetti 101, I-40129 Bologna, Italy.
Univ Gothenburg, Dept Chem & Mol Biol, Biomed Photon Grp, Gothenburg, Sweden.
Royal Inst Technol, KTH, Stockholm, Sweden; Nanologica AB, Sodertalje, Sweden.
Show others and affiliations
2017 (English)In: Journal of materials chemistry. B, ISSN 2050-750X, E-ISSN 2050-7518, no 17Article in journal (Refereed) Published
Abstract [en]

Three types of new label-free fluorescent mesoporous silica micro- and nanoparticles were prepared by controlled thermal decomposition of carboamino groups linked on the surface without compromising the drug loading capacity of the silica particles. Clofazimine, a lipophilic antibiotic drug with excellent in vitro activity against mycobacterium tuberculosis, was encapsulated inside these fluorescent particles to obtain multifunctional drug carriers of interest in the field of theranostics. The morphological features together with the photophysical properties of both powders and aqueous suspensions are described. The photophysical properties seem to be independent of the mesoporosity features but correlate with the residual carboamino functionalization. The particles are endowed with emission in the visible region and have fluorescence lifetimes of up to 9.0 ns that can be easily discriminated from intrinsic biological fluorescence. Furthermore, their fluorescence lifetime offers a promising tool to follow the release of the encapsulated drug which is not possible by means of simple fluorescence intensity. We report here a novel attractive theranostic platform enabling monitoring of drug release in biological environments by means of fluorescence lifetime.

Place, publisher, year, edition, pages
Royal Society of Chemistry, 2017. no 17
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:mau:diva-3960DOI: 10.1039/C7TB00198CISI: 000400501900014PubMedID: 32263718Scopus ID: 2-s2.0-85021713754Local ID: 24195OAI: oai:DiVA.org:mau-3960DiVA, id: diva2:1400784
Available from: 2020-02-28 Created: 2020-02-28 Last updated: 2024-06-17Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Valetti, Sabrina

Search in DiVA

By author/editor
Valetti, Sabrina
In the same journal
Journal of materials chemistry. B
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 29 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf